Kilmartin: Bristol-Meyers Squib to Pay RI $235K for Alleged False Marketing of Abilify
PROVIDENCE, R.I. — Rhode Island will receive $235,269 of a $19.5 million dollar, 42-state settlement with Bristol-Myers Squibb for alleged improper marketing of the drug Abilify, approved by the U.S. Food and Drug Administration for treatment of schizophrenia in 2002.